Literature DB >> 29385356

Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Anna M Marzeda1, Kim S Midwood1.   

Abstract

To protect against danger, the innate immune system must promptly and accurately sense alarm signals, and mount an appropriate response to restore homeostasis. One endogenous trigger of immunity is tenascin-C, a large hexameric protein of the extracellular matrix. Upregulated upon tissue injury and cellular stress, tenascin-C is expressed during inflammation and tissue remodeling, where it influences cellular behavior by interacting with a multitude of molecular targets, including other matrix components, cell surface proteins, and growth factors. Here, we discuss how these interactions confer upon tenascin-C distinct immunomodulatory capabilities that make this matrix molecule necessary for efficient tissue repair. We also highlight in vivo studies that provide insight into the consequences of misregulated tenascin-C expression on inflammation and fibrosis during a wide range of inflammatory diseases. Finally, we examine how its unique expression pattern and inflammatory actions make tenascin-C a viable target for clinical exploitation in both diagnostic and therapeutic arenas.

Entities:  

Keywords:  extracellular matrix; fibroblast; fibrosis; inflammation; inflammatory disease; innate immunity; integrin; macrophage; toll-like receptor 4

Mesh:

Substances:

Year:  2018        PMID: 29385356      PMCID: PMC5958381          DOI: 10.1369/0022155418757443

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  100 in total

1.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

2.  α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation.

Authors:  Masashi Kanayama; Junko Morimoto; Yutaka Matsui; Masahiro Ikesue; Keiko Danzaki; Daisuke Kurotaki; Koyu Ito; Toshimichi Yoshida; Toshimitsu Uede
Journal:  J Immunol       Date:  2011-10-28       Impact factor: 5.422

3.  Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury.

Authors:  Hirokazu Saiwai; Hiromi Kumamaru; Yasuyuki Ohkawa; Kensuke Kubota; Kazu Kobayakawa; Hisakata Yamada; Takehiko Yokomizo; Yukihide Iwamoto; Seiji Okada
Journal:  J Neurochem       Date:  2013-01-15       Impact factor: 5.372

4.  Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.

Authors:  Kiyohito Yamamoto; Koji Onoda; Yasuhiro Sawada; Kazuya Fujinaga; Kyoko Imanaka-Yoshida; Hideto Shimpo; Toshimichi Yoshida; Isao Yada
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

5.  Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration.

Authors:  Ayako Nakamura-Ishizu; Yuji Okuno; Yoshiki Omatsu; Keisuke Okabe; Junko Morimoto; Toshimitsu Uede; Takashi Nagasawa; Toshio Suda; Yoshiaki Kubota
Journal:  Blood       Date:  2012-05-02       Impact factor: 22.113

6.  Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation.

Authors:  Elena Jachetti; Sara Caputo; Stefania Mazzoleni; Chiara Svetlana Brambillasca; Sara Martina Parigi; Matteo Grioni; Ignazio Stefano Piras; Umberto Restuccia; Arianna Calcinotto; Massimo Freschi; Angela Bachi; Rossella Galli; Matteo Bellone
Journal:  Cancer Res       Date:  2015-03-25       Impact factor: 12.701

7.  Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages.

Authors:  Anna M Piccinini; Lorena Zuliani-Alvarez; Jenny M P Lim; Kim S Midwood
Journal:  Sci Signal       Date:  2016-08-30       Impact factor: 8.192

8.  Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells.

Authors:  Giorgio Napolitani; Eva V Acosta-Rodriguez; Antonio Lanzavecchia; Federica Sallusto
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

Review 9.  Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy.

Authors:  Michal Baniyash
Journal:  Cancer Immunol Immunother       Date:  2016-05-25       Impact factor: 6.968

10.  Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers.

Authors:  Lorena Zuliani-Alvarez; Anna M Marzeda; Claire Deligne; Anja Schwenzer; Fiona E McCann; Brian D Marsden; Anna M Piccinini; Kim S Midwood
Journal:  Nat Commun       Date:  2017-11-17       Impact factor: 14.919

View more
  27 in total

Review 1.  Revisiting the Tenascins: Exploitable as Cancer Targets?

Authors:  Richard P Tucker; Martin Degen
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

2.  Tenascin-C induction exacerbates post-stroke brain damage.

Authors:  Bharath Chelluboina; Anil K Chokkalla; Suresh L Mehta; Kahlilia C Morris-Blanco; Saivenkateshkomal Bathula; Sneha Sankar; Jin Soo Park; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2021-10-25       Impact factor: 6.960

3.  Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.

Authors:  Hiroyuki Kato; Sergio Duarte; Mary G Miller; Ronald W Busuttil; Ana J Coito
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

4.  Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.

Authors:  Claire Deligne; Devadarssen Murdamoothoo; Anís N Gammage; Martha Gschwandtner; William Erne; Thomas Loustau; Anna M Marzeda; Raphael Carapito; Nicodème Paul; Inés Velazquez-Quesada; Imogen Mazzier; Zhen Sun; Gertraud Orend; Kim S Midwood
Journal:  Cancer Immunol Res       Date:  2020-01-15       Impact factor: 11.151

5.  Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.

Authors:  Ding Ma; Senquan Liu; Bachchu Lal; Shuang Wei; Shuyan Wang; Daqian Zhan; Hao Zhang; Richard S Lee; Peisong Gao; Hernando Lopez-Bertoni; Mingyao Ying; Jian Jian Li; John Laterra; Mary Ann Wilson; Shuli Xia
Journal:  Cancer Res       Date:  2019-03-21       Impact factor: 12.701

Review 6.  Location, location, location: how the tissue microenvironment affects inflammation in RA.

Authors:  Christopher D Buckley; Caroline Ospelt; Steffen Gay; Kim S Midwood
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 20.543

7.  An immune response to the avascular lens following wounding of the cornea involves ciliary zonule fibrils.

Authors:  JodiRae DeDreu; Caitlin J Bowen; Caitlin M Logan; Sonali Pal-Ghosh; Paola Parlanti; Mary Ann Stepp; A Sue Menko
Journal:  FASEB J       Date:  2020-05-25       Impact factor: 5.191

8.  Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?

Authors:  Susan R Aungier; Alison J Cartwright; Anja Schwenzer; Jennifer L Marshall; Michael R Dyson; Peter Slavny; Kothai Parthiban; Aneesh Karatt-Vellatt; Ilfita Sahbudin; Eric Culbert; Patrick Hextall; Felix Il Clanchy; Richard Williams; Brian D Marsden; Karim Raza; Andrew Filer; Christopher Dominic Buckley; John McCafferty; Kim S Midwood
Journal:  Ann Rheum Dis       Date:  2018-12-14       Impact factor: 19.103

Review 9.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

10.  Airway Epithelial Cells Generate Pro-inflammatory Tenascin-C and Small Extracellular Vesicles in Response to TLR3 Stimuli and Rhinovirus Infection.

Authors:  Jake T Mills; Anja Schwenzer; Elizabeth K Marsh; Michael R Edwards; Ian Sabroe; Kim S Midwood; Lisa C Parker
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.